Biogen | Umsatzkosten



Cost Of Sales Veränderung Datum
AbbVie USD 4B 394M 2025-03
Acadia Pharmaceuticals USD 21.8M 2.95M 2024-12
ALKERMES USD 62.12M 984K 2024-12
Amgen USD 3.11B 198M 2024-12
Bayer EUR 5.72B 633M 2024-12
Biogen USD 583.5M 55.2M 2024-12
BioMarin Pharmaceutical USD 136.14M 52.32M 2024-12
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Eli Lilly USD 2.22B 179.6M 2025-03
Gilead Sciences USD 1.54B 41M 2025-03
Incyte USD 67.8M 14.58M 2025-03
Merck USD 2.76B 944M 2025-03
Moderna USD 90M 456M 2025-03
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Novartis USD 3.32B 90M 2024-12
Pfizer USD 2.59B 3.06B 2025-03
PTC Therapeutics USD 16.28M 5.44M 2024-12
Regeneron Pharmaceuticals USD 265.5M 299.9M 2025-03
Sanofi EUR 2.89B 618M 2025-03
Sanofi EUR 2.27B 1.81B 2024-12
Sarepta Therapeutics USD 132.3M 40.61M 2024-12
Teva Pharmaceutical Industries USD 2.11B 18M 2024-12
Ultragenyx Pharmaceutical USD 16.89M 4.13M 2024-12
United Therapeutics USD 277.5M 201.6M 2025-03
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



Biogen Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.